UNIGE document Scientific Article
previous document  unige:19646  next document
add to browser collection

Pharmacogenetics-based population pharmacokinetic analysis of efavirenz in HIV-1-infected individuals

Arab-Alameddine, M.
Di Iulio, J.
Rotger, M.
Lubomirov, R.
Cavassini, M.
Fayet, A.
Decosterd, L. A.
show hidden authors show all authors [1 - 12]
Published in Clinical pharmacology & therapeutics. 2009, vol. 85, no. 5, p. 485-494
Abstract Besides CYP2B6, other polymorphic enzymes contribute to efavirenz (EFV) interindividual variability. This study was aimed at quantifying the impact of multiple alleles on EFV disposition. Plasma samples from 169 human immunodeficiency virus (HIV) patients characterized for CYP2B6, CYP2A6, and CYP3A4/5 allelic diversity were used to build up a population pharmacokinetic model using NONMEM (non-linear mixed effects modeling), the aim being to seek a general approach combining genetic and demographic covariates. Average clearance (CL) was 11.3 l/h with a 65% interindividual variability that was explained largely by CYP2B6 genetic variation (31%). CYP2A6 and CYP3A4 had a prominent influence on CL, mostly when CYP2B6 was impaired. Pharmacogenetics fully accounted for ethnicity, leaving body weight as the only significant demographic factor influencing CL. Square roots of the numbers of functional alleles best described the influence of each gene, without interaction. Functional genetic variations in both principal and accessory metabolic pathways demonstrate a joint impact on EFV disposition. Therefore, dosage adjustment in accordance with the type of polymorphism (CYP2B6, CYP2A6, or CYP3A4) is required in order to maintain EFV within the therapeutic target levels.
Keywords AdultAgedAllelesAnti-HIV Agents/administration & dosage/*pharmacokinetics/therapeutic useAryl Hydrocarbon Hydroxylases/genetics/metabolismBenzoxazines/administration & dosage/*pharmacokinetics/therapeutic useBody WeightCytochrome P-450 CYP3A/genetics/metabolismDose-Response Relationship, DrugFemaleHIV Infections/drug therapy/*geneticsHumansMaleMiddle AgedModels, BiologicalNonlinear DynamicsOxidoreductases, N-Demethylating/genetics/metabolism*Pharmacogenetics*Polymorphism, Genetic
PMID: 19225447
Full text
(ISO format)
ARAB-ALAMEDDINE, M. et al. Pharmacogenetics-based population pharmacokinetic analysis of efavirenz in HIV-1-infected individuals. In: Clinical pharmacology and therapeutics, 2009, vol. 85, n° 5, p. 485-494. doi: 10.1038/clpt.2008.271 https://archive-ouverte.unige.ch/unige:19646

517 hits

1 download


Deposited on : 2012-04-23

Export document
Format :
Citation style :